Aprea Therapeutics Ownership | Who Owns Aprea Therapeutics?


OverviewForecastRevenueFinancialsChart

Aprea Therapeutics Ownership Summary


Aprea Therapeutics is owned by 0.02% institutional investors, 11.75% insiders, and 88.23% retail investors. Nbc securities is the largest institutional shareholder, holding 0.02% of APRE shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.67% of its assets in Aprea Therapeutics shares.

APRE Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAprea Therapeutics0.02%11.75%88.23%
SectorHealthcare Stocks 49.65%8.78%41.57%
IndustryBiotech Stocks 46.85%8.74%44.40%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Nbc securities899.000.02%$3.00K
Princeton global asset management---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nbc securities899.000.00%$3.00K
Princeton global asset management---

Top Buyers

HolderShares% AssetsChange
Nbc securities899.000.00%-
Princeton global asset management---100.00

Top Sellers

HolderShares% AssetsChange
Princeton global asset management---100.00
Nbc securities899.000.00%-

Sold Out

HolderChange
Princeton global asset management-100.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241-899--3302.80%----
Jun 30, 20241-50.00%899-10.01%-2809.42%--100.00%--
Mar 31, 20242100.00%999899.00%-382025.93%1---
Dec 31, 20231-100--37000.00%----
Sep 30, 20231-100--28187.10%----

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv145.28K2.67%-
Vanguard Institutional Extnd Mkt Idx Tr28.56K0.53%-
Fidelity Extended Market Index25.84K0.48%-104.00
DFA US Targeted Value I7.98K0.15%2.90K
Fidelity Series Total Market Index5.96K0.11%4.21K
Dimensional US Targeted Value ETF5.08K0.09%-
Fidelity Total Market Index4.49K0.08%-
DFA US Core Equity 1 I2.19K0.04%-
Fidelity Nasdaq Composite Index2.10K0.04%-
Northern Trust Extended Eq Market Idx2.05K0.04%-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 18, 2024Duey Marc-Sell$29.58K
Oct 23, 2024Gilad Oren President/CEOBuy$1.96K
Oct 16, 2024Duey Marc-Buy$131.70K
Oct 15, 2024Gilad Oren President/CEOBuy$725.00
Oct 14, 2024Duey Marc-Buy$490.20

Insider Transactions Trends


DateBuySell
2024 Q491
2024 Q2--
2024 Q112-
2023 Q3--
2023 Q22-

APRE Ownership FAQ


Who Owns Aprea Therapeutics?

Aprea Therapeutics shareholders are primarily institutional investors at 0.02%, followed by 11.75% insiders and 88.23% retail investors. The average institutional ownership in Aprea Therapeutics's industry, Biotech Stocks , is 46.85%, which Aprea Therapeutics falls below.

Does Blackrock own Aprea Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Aprea Therapeutics.

Who is Aprea Therapeutics’s biggest shareholder by percentage of total assets invested?

Nbc securities is Aprea Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 899 Aprea Therapeutics shares, valued at 3K$.

Who is the top mutual fund holder of Aprea Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aprea Therapeutics shares, with 2.67% of its total shares outstanding invested in 145.28K Aprea Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools